IPCALAB 1520 CE CALL indicators chart analysis IPCA Laboratories Limited options price chart strike 1520 CALL
Options premium and indicators chart analysis for IPCALAB 1520 CE CALL indicators chart analysis IPCA Laboratories Limited options price chart strike 1520 CALL
IPCA Laboratories Limited IPCALAB trades in NSE under Pharmaceuticals NSE
Premium of IPCALAB 1520 CALL CE Nov 28 2024
Premium of CALL (CE) of strike 1520 is at: 35.15 on 13 Nov 2024
CALL opened at 48.00 and traded inside a Low-High range of 28.65-49.20
as on 13 Wed Nov 2024
The underlying equity is trading at 1536.55 which means that CALL of strike 1520 is ITM CALL option (in the money)
Lot size of IPCALAB IPCA Laboratories Limited is 650
Total Open Interest for CALL (CE) of strike 1520 is 57,850
Price action analysis of 1520 CALL based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of 1520 CALL based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Indicators are giving a sell signal for buyers, but an entry signal is generated by indicators for sellers of 1520 CALL of IPCA Laboratories Limited
Click here to view most profitable CE and PE for IPCA Laboratories Limited, both for buyers and sellers | IPCALAB Most Active Call Put Options
Date | Underlying price | CE price | CE open | CE high | CE low | CE volume | CE OI | OI Change |
13 Wed Nov | 1536.55 | 35.15 | 48.00 | 49.20 | 28.65 | -60 | 37,602,500 | 1383.3% |
12 Tue Nov | 1504.85 | 90.00 | 82.00 | 94.00 | 80.00 | 92 | 2,535,000 | -25% |
11 Mon Nov | 1559.50 | 46.70 | 56.60 | 56.65 | 42.00 | -33 | 3,380,000 | 300% |
08 Fri Nov | 1531.30 | 70.00 | 0.00 | 0.00 | 0.00 | 0 | 845,000 | 0% |
07 Thu Nov | 1558.65 | 70.00 | 70.00 | 70.00 | 70.00 | -22 | 845,000 | 100% |
06 Wed Nov | 1558.40 | 90.00 | 90.00 | 90.00 | 90.00 | 0 | 422,500 | 0% |